Clinical outcomes of CDK4/6 inhibitors in patients with bone only metastatic breast cancer

被引：1
|
作者：
Mardani, Mahta
Noordeen, Suleyman
Clifton, Katherine
Ma, Cynthia
Luo, Jingqin
Xi, Jing
Bagegni, Nusayba
Ademuyiwa, Foluso
Suresh, Rama
Frith, Ashley
Davis, Andrew
Bose, Ron
Peterson, Lindsay
Thomas, Shana
Tao, Yu
Kobayashi, Takayuki
Xiang, Jingyu
Xu, Yalin
Su, Xinming
Weilbaecher, Katherine
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-05-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-05-05
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer
    Ettl, Johannes
    Huober, Jens
    Lueftner, Diana
    Marme, Frederik
    Wuerstlein, Rachel
    BREAST CARE, 2017, 12 (02) : 118 - 120
  • [2] Effect of timing of recurrence on outcomes in patients with metastatic breast cancer treated with CDK4/6 inhibitors
    Niraula, Sujan
    Villamarin, Diego
    Smith, Tae
    Babbra, Ramandeep
    Mahant, Akhil
    Strawderman, Myla S.
    Kharel, Zeni
    Tinkham, Christie
    Tiongson, Michael
    Bamarajpet, Nikhil
    Houshyar, Samin
    Kim, Erica
    Weiss, Anna
    Falkson, Carla Isadora
    O'Regan, Ruth
    Zhang, Huina
    Dhakal, Ajay
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] An Overview of the Roles of CDK4/6 Inhibitors in Metastatic Breast Cancer Elderly Patients
    Pacilio, C. A. R. M. E. N.
    Rosati, G. E. R. A. R. D. O.
    Crispo, A. N. N. A.
    Bimonte, S. A. B. R. I. N. A.
    DI Rella, F. R. A. N. C. E. S. C. A.
    Nuzzo, F. R. A. N. C. E. S. C. O.
    DE Laurentiis, M. I. C. H. E. L. I. N. O.
    IN VIVO, 2023, 37 (04): : 1445 - 1449
  • [4] CDK4/6 inhibitors in breast cancer
    Dukelow, Tim
    Kishan, Divya
    Khasraw, Mustafa
    Murphy, Conleth G.
    ANTI-CANCER DRUGS, 2015, 26 (08) : 797 - 806
  • [5] Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis
    Ceylan, Furkan
    Mehdiyev, Mirmehdi
    Bilgin, Burak
    Tenekeci, Ates Kutay
    Yalcin, Bulent
    Akinci, M. Bulent
    Dede, Didem Sener
    Sendur, Mehmet Ali Nahit
    Algin, Efnan
    Yucel, Sebnem
    CANCERS, 2025, 17 (03)
  • [6] ADHERENCE TO CDK4/6 INHIBITORS AMONG PATIENTS WITH METASTATIC BREAST CANCER: A MULTILEVEL PERSPECTIVE
    O'Neill, Suzanne C.
    Pensak, Nicole Amoyal
    Vadaparampil, Susan T.
    Lynce, Filipa
    Graham, Deena M. A.
    Conley, Claire C.
    Lopez, Katherine
    ANNALS OF BEHAVIORAL MEDICINE, 2019, 53 : S276 - S276
  • [7] An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer
    Marie Robert
    Jean-Sébastien Frenel
    Emmanuelle Bourbouloux
    Dominique Berton Rigaud
    Anne Patsouris
    Paule Augereau
    Carole Gourmelon
    Mario Campone
    Drugs, 2018, 78 : 1353 - 1362
  • [8] An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer
    Robert, Marie
    Frenel, Jean-Sebastien
    Bourbouloux, Emmanuelle
    Rigaud, Dominique Berton
    Patsouris, Anne
    Augereau, Paule
    Gourmelon, Carole
    Campone, Mario
    DRUGS, 2018, 78 (13) : 1353 - 1362
  • [9] Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer
    George, Mridula A.
    Qureshi, Sadaf
    Omene, Coral
    Toppmeyer, Deborah L.
    Ganesan, Shridar
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Real-World Outcomes of CDK4/6 Inhibitors Treatment in Metastatic Breast Cancer in Romania
    Miron, Andreea-Iuliana
    Anghel, Alexandra-Valentina
    Barnonschi, Andrei-Alexandru
    Mitre, Ruxandra
    Liscu, Horia-Dan
    Gainariu, Estera
    Patru, Raluca
    Coniac, Simona
    DIAGNOSTICS, 2023, 13 (11)
12345